Testing effectiveness (Phase 2)Ended earlyNCT03948334
What this trial is testing
Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients
Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 123
Showing 20 of 0 results